Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Opin Rheumatol ; 26(2): 169-75, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24445479

ABSTRACT

PURPOSE OF REVIEW: Although uricosuric agents provide the most time-honoured approach to the control of hyperuricemia, their place in the armamentarium has been eclipsed by that of xanthine oxidase inhibitors. This review considers the potential for uricosuric agents from the perspective of recent progress in the understanding of urate transport systems. RECENT FINDINGS: No new agents have yet become available, but promising new drugs are under development. Better understanding of the transporters URAT1 and ABCG2 in particular would appear to provide opportunities for more selective, better tolerated agents to increase the renal clearance of uric acid and thereby control hyperuricemia. SUMMARY: Conceptually, modest inhibition of renal tubular reabsorption should provide effective relief for the millions of individuals who are now hyperuricemic and who suffer from its principal consequence, gout.


Subject(s)
Hyperuricemia/drug therapy , Uricosuric Agents/therapeutic use , ATP Binding Cassette Transporter, Subfamily G, Member 2 , ATP-Binding Cassette Transporters/metabolism , Drug Discovery , Enzyme Inhibitors/therapeutic use , Glucose Transport Proteins, Facilitative/metabolism , Gout/drug therapy , Gout/metabolism , Humans , Hydrochlorothiazide/adverse effects , Hyperuricemia/chemically induced , Hyperuricemia/metabolism , Kidney Tubules, Proximal/drug effects , Kidney Tubules, Proximal/metabolism , Neoplasm Proteins/metabolism , Organic Anion Transporters/metabolism , Organic Cation Transport Proteins/metabolism , Probenecid/therapeutic use , Uric Acid/metabolism , Xanthine Oxidase/antagonists & inhibitors
2.
Mech Ageing Dev ; 126(4): 467-73, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15722105

ABSTRACT

Angiogenesis, the formation of new vessels from pre-existing vasculature, is impaired in aging. This is due, in part, to a lack of regulatory molecules such as nitric oxide (NO). We wished to test the hypothesis that there are deficits in the pathways that mediate NO production during angiogenesis (as defined by fibrovascular invasion into a polyvinyl alcohol (PVA) sponge implant), in aged mice in comparison to young mice. Sponges were implanted subcutaneously in young (6-8 months old, n=11) and aged (23-25 months old, n=13) mice and sampled at 14 and 19 days. Sections from the implants were stained with antibodies against vascular endothelial growth factor receptor 2 (VEGFR-2), Akt, phosphorylated Akt (p-Akt), endothelial nitric oxide synthase (eNOS), phosphorylated eNOS (p-eNOS), inducible NOS (iNOS), and 3-nitrotyrosine (3-NT, a marker for nitrosylated proteins). Expression of VEGFR-2 was similar in the sponges of young and aged mice. Moreover, there were no significant differences in levels of Akt or its phosphorylated form in sponges from young and aged mice at 14 and 19 d. In marked contrast, levels of eNOS, p-eNOS and iNOS were significantly decreased in sponges from aged mice relative to young mice (p<0.02 for eNOS, p-eNOS and <0.01 for iNOS between young and aged mice). Concomitantly, there was diminished expression of 3-NT in the sponges from aged mice (p<0.05). Our data indicate that defects in the activation of nitric oxide synthases result in decreased NO production in aged tissues relative to young tissues. We propose that the subsequent lack of NO contributes to impaired angiogenesis in aging.


Subject(s)
Aging/metabolism , Gene Expression Regulation, Enzymologic/physiology , Neovascularization, Physiologic/physiology , Nitric Oxide Synthase/biosynthesis , Signal Transduction/physiology , Animals , Enzyme Activation/physiology , Mice , Nitric Oxide/biosynthesis , Nitric Oxide Synthase Type II , Nitric Oxide Synthase Type III
SELECTION OF CITATIONS
SEARCH DETAIL
...